Patents, commercialization and the Canadian stem cell research community

Author： Caulfield Timothy   Ogbogu Ubaka   Murdoch Charles   Einsiedel Edna  

Publisher： Future Medicine

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.3, Iss.4, 2008-07, pp. : 483-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patents in Limbal Stem Cell Biology

By  

Recent Patents on Regenerative Medicine, Vol. 1, Iss. 2, 2011-05 ,pp. : 207-212

Bentham Science Publishers

Access to resources Recommend Favorite

Commercialization challenges associated with induced pluripotent stem cell-based products

By Smith Devyn  

Regenerative Medicine, Vol. 5, Iss. 4, 2010-07 ,pp. : 593-603

Future Medicine

Access to resources Recommend Favorite

Catalyzing stem cell research

By Willemse Lisa   Lyall Drew   Rudnicki Michael  

Regenerative Medicine, Vol. 3, Iss. 5, 2008-09 ,pp. : 761-764

Future Medicine

Access to resources Recommend Favorite

Recent Patents on Stem Cell-Mediated Cartilage Regeneration and Repair

By  

Recent Patents on Regenerative Medicine, Vol. 1, Iss. 1, 2011-01 ,pp. : 118-122

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on MicroRNA-Induced Pluripotent Stem Cell Generation

By  

Recent Patents on Regenerative Medicine, Vol. 3, Iss. 1, 2013-01 ,pp. : 5-16

Bentham Science Publishers

Access to resources Recommend Favorite